Divalproex Long-Acting Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Divalproex Long-Acting Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex sodium, Divalproex
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex Long-Acting Tablets-Molindone
- Divalproex Long-Acting Tablets-Mometasone (Oral Inhalation)
- Divalproex Long-Acting Tablets-Mometasone and Formoterol
- Divalproex Long-Acting Tablets-Mometasone and formoterol Inhalation
- Divalproex Long-Acting Tablets-Mometasone Cream
- Divalproex Long-Acting Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Divalproex sodium
- Mogamulizumab-kpkc Intravenous-Divalproex Sprinkle
- Mogamulizumab-kpkc Intravenous-Divalproex Sprinkle Capsules
- Mogamulizumab-kpkc Intravenous-Divigel
- Mogamulizumab-kpkc Intravenous-Divigel 0.75 mg/packet for use on skin
- Mogamulizumab-kpkc Intravenous-Divigel Transdermal